Physician

William Thomas Varnado

According to 2025 Medicare claims, William Varnado (NPI: 1790027589) practices hematology/oncology in the Baton Rouge, LA market, with the plurality of this provider's patient population coming from E. Baton Rouge, LA. This provider's primary affiliated billing organization is MARY BIRD PERKINS CANCER CENTER (NPI: 1295833580; TIN: 237010520) and primary practice location at 70809-3482.

Varnado's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 358 traditional Medicare patients, billed 73,283 HCPCS/CPT codes, and received $1,645,999 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 2,474 prescription claims across 392 beneficiaries totaling $3,900,117 in drug costs, led by Verzenio (Abemaciclib). Open Payments data shows 43 records totaling $63,436. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $5,229 to $1,645,999. Similarly, Part D prescription costs have moved sharply higher in recent years, from $33,840 to $3,900,117. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$823K$1.6M2016 Medicare payment: $5,229 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $4,905 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $3,589 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $27,409 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $94,218 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $903,174 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $1,373,172 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $1,645,999 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
20164269$5,229
20173969$4,905
2018N/RN/RN/R
20191937$3,589
202075278$27,409
2021173857$94,218
202226448,778$903,174
202330559,074$1,373,172
202435873,283$1,645,999

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$2.0M$3.9M2015 Drug cost: $33,840 (USD; Tot_Drug_Cst)2016 Drug cost: $14,482 (USD; Tot_Drug_Cst)2017 Drug cost: $2,045 (USD; Tot_Drug_Cst)2018 Drug cost: $1,488 (USD; Tot_Drug_Cst)2020 Drug cost: $132,857 (USD; Tot_Drug_Cst)2021 Drug cost: $786,828 (USD; Tot_Drug_Cst)2022 Drug cost: $1,132,482 (USD; Tot_Drug_Cst)2023 Drug cost: $1,938,360 (USD; Tot_Drug_Cst)2024 Drug cost: $3,900,117 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201534343$33,840
201628208$14,482
20172461$2,045
20181923$1,488
2019N/RN/RN/R
202073211$132,857
2021203953$786,828
20222191,255$1,132,482
20233131,945$1,938,360
20243922,474$3,900,117

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99205New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more7474$154
99215Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more157675$128
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more219462$89
96413Administration of chemotherapy into vein, 1 hour or less54231$88
96375Injection of additional new drug or substance into vein48301$11

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
VerzenioAbemaciclib33924$508,589
XtandiEnzalutamide341,020$444,301
Abiraterone AcetateAbiraterone Acetate1313,930$330,955
AlecensaAlectinib Hcl13390$279,712
KisqaliRibociclib Succinate16448$233,991

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.39$915Medtronic, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.4$62,520Merck Sharp & Dohme LLC
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for William Thomas Varnado?

Tedicare shows public-source Medicare data for William Thomas Varnado (NPI 1790027589), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does William Thomas Varnado have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to William Thomas Varnado?

William Thomas Varnado is linked to MARY BIRD PERKINS CANCER CENTER (billing NPI 1295833580) in the available physician profile data.

Does William Thomas Varnado have Open Payments data?

William Thomas Varnado has 43 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.